We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cambridge Nutritional Sciences Plc | LSE:CNSL | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.15 | -3.80% | 3.80 | 3.70 | 3.90 | 3.95 | 3.80 | 3.95 | 1,230,932 | 13:10:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices-holdng Companies,nec | 8.19M | -3.86M | -0.0162 | -2.35 | 9.03M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/11/2023 10:31 | Just 75,000 at offer price now. | broken_arrow1 | |
23/11/2023 09:20 | Poised to move up shortly, online buy limits have dropped, the RSI has come back from overbought to neutral, chart indicators look positive. | broken_arrow1 | |
23/11/2023 08:59 | A pat on the back for the Gracious Fellow who suggested to readers the interim numbers would be stellar. So what's next, well wait and see, soon enough Mr Market will awake to the value disconnect and start buying, the modest fellow suggested some may be happy with 5p a share, the Gracious Fellows suggests far more. Never underestimate the power of a re-rate once it starts ! | yasxii | |
23/11/2023 08:20 | McGregor (#51) looks like a basher from the LSE board. If so, ignore. That Board is wrecked. Cash increasing, now over 1.85 pps on a share trading at 2.6 pps pre results. Fill boots. | wbodger | |
23/11/2023 08:07 | Premium being asked for £4k+ of stock currently. Remember the chart gap of 3.75p needs filling. | broken_arrow1 | |
23/11/2023 08:02 | A great set of numbers today, sales up 44%, margins up and cash £4.4m - current market value only £6m. The bashers are proving futile and not embellishing the true facts, the company has stated many many times the DHSC claim has no foundation, on the contrary the are pursuing a significant counter claim which could be in a range of £3m to £10m The company is in a strong growth phase, it is under radar to most investors yet seems to have attracted the bashing community on LSE who have been working 24/7 for over a year now. Strong suggestions the company is will be taken over, at current levels the product suite is barely valued at £2m despite IRO £9m annual sales (and growing) | one2go | |
23/11/2023 07:39 | Making a loss despite boost of deferred revenue. H2 forecast lower than H1 so no growth. "Operationally we continue to evaluate alternative technologies for our flagship product, FoodPrint®, to ensure the long-term future of the product." As things stand their main product doesn't have a long term future. Still owe DHSC £2.5m. | mr macgregor | |
22/11/2023 16:17 | Last chance to get in before tomorrows results and update !!! | one2go | |
22/11/2023 11:52 | Online buy limits have reduced this morning, now only £5k of stock at offer price then it's a premium. | broken_arrow1 | |
22/11/2023 09:40 | This is an under radar gem of a company yasXII, a likely takeover target also. It will be interesting to see what the brokers have to say post results, once through £10m m/cap it will start to attract institutional investors, the re-rate could snowball. The last broker note, albeit back in January, had a conservative price target of 12p a share. | thecoyone | |
22/11/2023 08:57 | The Gracious Fellow is expecting to see some very robust numbers from this outfit tomorrow, the forward statement should be exceptionally bullish, would remind readers of comments made by the company recently. Some may not see the relevance in pulling the proposed share consolidation, the nominal value being 4p, would have risen to 10p, it seems the company has that share price in sight, you see they would not have been able to equity raise under it. Buy the low. 'Maintaining our market leading position whilst targeting organic growth to gain momentum and create value for our shareholders' 'We maintain a very strong order book' 'We remain well-funded to deliver against our strategic objectives' 'Launch of our new digital "app", MyHealthTracker, will support our strong position in the market' 'We are implementing the final parts of the turnaround strategy' | yasxii | |
20/11/2023 11:13 | That's a big seller with a lot left to shift. So backing off from taking a interest for now | dave4545 | |
16/11/2023 15:57 | The Gracious Fellow has taken a very positive stance on this company, having perused the last financials one draws attention to a number of exceptional items which occurred, these are long gone - good riddance. The order book had a £2m forward carry into this FY, which means the interim numbers next week should be stellar. As ever the Gracious, let alone modest chap, suggests a good tuck in at current levels will reward handsomely. | yasxii | |
16/11/2023 08:07 | The window for buying size in a stock as tightly held as this is limited, there have been a number of chunky buys recently, declared late, it is clear there are background orders being filled. It does look like some big hitters are loading up. That 3.75p chart gap needs to be filled also. | broken_arrow1 | |
15/11/2023 20:21 | The clock is ticking down on getting a cheap entry point IMO, next week the interim results are announced, the 1st clean numbers as the new branded company with no legacy write offs etc. The cash balance as of 31st March was stated as £5.1m the current market value is £6m, they had FY sales of £7.5m but started this FY with a bulging order book of £2.6m and their Chinese customer placing orders once again. In a nutshell CNSL is s cheap as chips. | thecoyone | |
15/11/2023 07:50 | 750,000 shares were bought yesterday in 3 late declared trades, this stock is clearly in demand and investors waking up to the chronic undervaluation. Still a long way from the last broker 'conservative' price target of 12p a share. Cheap as chips !! | one2go | |
14/11/2023 09:54 | One suspects there are larger background buy orders ongoing, there have been many late declared trades (dressed as sells) however the stock continues to move quickly on very small buy orders. I would not be surprised if some entity is building an under radar position therefore. Time will tell but there appears to be a clear trend reversal ongoing and that gap to 3.7p sits there like a open barn door. | broken_arrow1 | |
14/11/2023 09:11 | I tried to buy at 2.4p and then 2.5p nothing doing So if it shakes down I might take a interest | dave4545 | |
14/11/2023 08:57 | DaveAre you interested in these too? | countbasie1 | |
14/11/2023 08:27 | Can buy now at 2.7p mid price | dave4545 | |
14/11/2023 07:57 | Looks like I timed my entry to perfection, will be acquiring more today, let us see where the share price goes, the company suggests it has a suite of world class products but has a EV of only circa £1m ?? Healthy cash balance (circa £4m) & no worries about dilution therefore. No wonder the market is reluctant to sell shares at current levels. Fair value seems to be circa £25m or 10p a share. | thecoyone | |
13/11/2023 14:27 | Gentlemen. The Gracious Fellow has been tucking in again today, remember it is better to arrive early than late, when the market is offering up £50 notes for £5 it would be silly not to take advantage. Charts, online limits, broker targets do not concern the Gracious Fellow, all part of a process nonetheless. Some feel 5p a share may be a sensible level, well it may be for some, do not underestimate the power of recovery in these tiddlers, set your sights far higher. | yasxii | |
13/11/2023 13:45 | Hardly anything available online currently, one wonders if shorts are closing, if so expect upside fireworks. There is a chart gap to fill to 3.75p as well. | broken_arrow1 | |
13/11/2023 13:33 | Some shrewd buying here, broker comment from Q1. Their conservative target was 12p a share. | one2go |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions